Nuvalent (NUVL) EBT (2020 - 2026)
Nuvalent (NUVL) posted EBT of -$109.1 million for Q1 2026, up 7.97% on a QoQ basis from -$118.6 million in Q4 2025, and down 29.24% year-over-year from -$154.2 million in Q1 2025.
Nuvalent (NUVL) EBT (2020 - 2026) Analysis & Trends
Nuvalent's EBT history runs 7 years deep, the most recent figure standing at -$109.1 million for Q1 2026.
- Quarterly EBT fell 29.24% year-over-year to -$109.1 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$449.5 million (down 49.67% YoY) and the FY2025 annual result came in at -$424.8 million, down 63.39% from the prior year.
- EBT was -$109.1 million for Q1 2026 at Nuvalent, up from -$118.6 million in the prior quarter.
- Across five years, EBT topped out at -$18.6 million in Q1 2022 and bottomed at -$122.3 million in Q3 2025.
- A 5-year average of -$59.2 million and a median of -$44.1 million in 2024 frame the typical range for EBT.
- Peak annual rise in EBT reached 32.65% in 2022, while the deepest fall reached 201.38% in 2022.
- Nuvalent's EBT stood at -$27.5 million in 2022, then tumbled by 39.44% to -$38.3 million in 2023, then sank by 94.8% to -$74.6 million in 2024, then slumped by 58.94% to -$118.6 million in 2025, then increased by 7.97% to -$109.1 million in 2026.
- Business Quant data shows NUVL's EBT at -$109.1 million in Q1 2026, -$118.6 million in Q4 2025, and -$122.3 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -36.97 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 259.22 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | -3.49 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 1.25 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 831.20 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | -26.94 Mn |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 541.00 Mn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | -453.82 Mn |
| 10 | Nuvalent | 9.75 Bn | 9.75 Bn | - | -109.11 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -109.11 Mn |
| Dec 31, 2025 | -118.55 Mn |
| Sep 30, 2025 | -122.31 Mn |
| Jun 30, 2025 | -99.51 Mn |
| Mar 31, 2025 | -84.43 Mn |
| Dec 31, 2024 | -74.59 Mn |
| Sep 30, 2024 | -84.31 Mn |
| Jun 30, 2024 | -57.00 Mn |
| Mar 31, 2024 | -44.10 Mn |
| Dec 31, 2023 | -38.29 Mn |
| Sep 30, 2023 | -33.65 Mn |
| Jun 30, 2023 | -29.09 Mn |
| Mar 31, 2023 | -25.19 Mn |
| Dec 31, 2022 | -27.46 Mn |
| Sep 30, 2022 | -20.58 Mn |
| Jun 30, 2022 | -19.60 Mn |
| Mar 31, 2022 | -18.57 Mn |
| Dec 31, 2021 | -40.78 Mn |
| Sep 30, 2021 | -12.43 Mn |
| Jun 30, 2021 | -9.85 Mn |